Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,224,600 | 1,144,000 | 1,410,100 | 1,042,600 | 872,500 |
| Marketable Securities | 473,000 | 500,500 | 453,800 | 466,700 | 381,700 |
| Receivables | 876,900 | 836,900 | 802,100 | 816,900 | 779,300 |
| Inventories | 1,207,300 | 1,168,200 | 1,032,400 | 980,200 | 914,300 |
| Other current assets | 250,600 | 239,300 | 235,800 | 217,400 | 190,300 |
| TOTAL | $4,170,500 | $4,035,700 | $4,067,500 | $3,647,000 | $3,257,200 |
| Non-Current Assets | |||||
| PPE Net | 1,767,900 | 1,749,400 | 1,681,300 | 1,662,200 | 1,646,000 |
| Investments And Advances | 455,600 | 583,900 | 704,600 | 856,200 | 1,066,700 |
| Intangibles | 1,699,600 | 1,681,900 | 1,727,200 | 1,730,900 | 1,755,200 |
| Other Non-Current Assets | 1,642,700 | 1,312,300 | 1,190,199 | 1,107,700 | 926,100 |
| TOTAL | $5,565,800 | $5,327,500 | $5,303,299 | $5,357,000 | $5,394,000 |
| Total Assets | $9,736,300 | $9,363,200 | $9,370,800 | $9,004,000 | $8,651,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 212,300 | 201,400 | 190,600 | 193,000 | 180,800 |
| Accrued Expenses | 873,700 | 969,100 | 1,024,000 | 939,900 | 876,100 |
| TOTAL | $1,110,800 | $1,195,400 | $1,238,900 | $1,157,200 | $1,082,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 597,200 | 597,000 | 596,800 | 596,700 | 596,500 |
| Other Non-Current Liabilities | 842,800 | 851,600 | 809,200 | 805,200 | 910,700 |
| TOTAL | $1,439,100 | $1,448,400 | $1,404,800 | $1,400,300 | $1,507,200 |
| Total Liabilities | $2,549,900 | $2,643,800 | $2,643,700 | $2,557,500 | $2,589,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 602,600 | 601,300 | 606,500 | 607,916 | 606,218 |
| Common Shares | 651,800 | 650,500 | 649,900 | 649,100 | 647,100 |
| Retained earnings | 9,344,300 | 8,992,400 | 8,622,500 | 8,237,600 | 7,930,500 |
| Other shareholders' equity | -164,500 | -172,900 | -180,600 | -184,700 | -170,900 |
| TOTAL | $7,186,400 | $6,719,400 | $6,727,100 | $6,446,500 | $6,062,000 |
| Total Liabilities And Equity | $9,736,300 | $9,363,200 | $9,370,800 | $9,004,000 | $8,651,200 |